From 4f00957efb164f13136fb875d324a5159a6087ce Mon Sep 17 00:00:00 2001
From: Pan Zhao <2653424179@qq.com>
Date: Tue, 1 Oct 2024 09:54:02 +0000
Subject: [PATCH] =?UTF-8?q?=E4=BF=AE=E6=94=B9=E4=BA=86=E4=B8=BB=E9=A1=B5?=
 =?UTF-8?q?=E7=9A=84From=20both=20environmental=20and=20human=20health=20p?=
 =?UTF-8?q?rotection=20perspectives,=20the=20design=20of=20the=20safety=20?=
 =?UTF-8?q?module=20aims=20to=20detect=20environmental=20variations=20insi?=
 =?UTF-8?q?de=20and=20outside=20the=20human=20body,=20such=20as=20temperat?=
 =?UTF-8?q?ure=20and=20oxygen=20concentration,=20to=20induce=20bacterial?=
 =?UTF-8?q?=20death.=20This=20ensures=20that=20the=20bacteria=20do=20not?=
 =?UTF-8?q?=20cause=20environmental=20pollution=20after=20being=20expelled?=
 =?UTF-8?q?.=E6=96=87=E6=9C=AC?=
MIME-Version: 1.0
Content-Type: text/plain; charset=UTF-8
Content-Transfer-Encoding: 8bit

---
 src/contents/safety.tsx | 1 +
 1 file changed, 1 insertion(+)

diff --git a/src/contents/safety.tsx b/src/contents/safety.tsx
index 9e02e00..262d2a7 100644
--- a/src/contents/safety.tsx
+++ b/src/contents/safety.tsx
@@ -89,6 +89,7 @@ The next page details the security measures and considerations our team has take
                 <p className="indent">Escherichia coli Nissle 1917 is an oral probiotic commonly used to treat various gastrointestinal diseases, including diarrhea, ulcerative colitis, etc.</p>
                 <h3>2.2Parts Safety</h3>
                 <h3>2.3Suicidal System</h3>
+                <p className="indent">From both environmental and human health protection perspectives, the design of the safety module aims to detect environmental variations inside and outside the human body, such as temperature and oxygen concentration, to induce bacterial death. This ensures that the bacteria do not cause environmental pollution after being expelled.</p>
                 <h3>2.4Safety Module</h3>
                 <p className="indent">Conversely, there is a risk of excessive proliferation of the engineered E. coli within the human body, necessitating the development of controllable switches to regulate bacterial growth and death effectively. </p>
                 <p className="indent">Additionally, we recognize that abdominal infections are a significant cause of recurrent hepatic encephalopathy and can lead to death. In response, we aim to develop an engineered bacterium capable of resisting inflammation and repairing the intestinal barrier. </p>
-- 
GitLab